Wu, Yu
Vora, Lalitkumar K.
Donnelly, Ryan F.
Singh, Thakur Raghu Raj http://orcid.org/0000-0001-7582-2082
Article History
Accepted: 24 May 2022
First Online: 17 June 2022
Declarations
:
: This study was performed without use of animals and human volunteers. Therefore, this is not applicable.
: All the authors provided consent for publication.
: Thakur Raghu Raj Singh is an inventor of patents and founder of Re-Vana Therapeutics Ltd. The resulting potential conflict of interest has been disclosed and is managed by Queen's University Belfast. The companies had no role in the design of the manuscript, in the collection, analyses or interpretation of the various studies reviewed, in the writing of the manuscript. Other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.